


Panora Biosciences, Inc
Biotechnology Research • 725 San Aleso Ave, Suite 3D, United States • 1-10 Employees
Company overview
| Headquarters | 725 San Aleso Ave, Suite 3D, Sunnyvale, California 94085, US |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Panora Biosciences, Inc
Lin Cheng
CEO
About Panora Biosciences, Inc
Panora Biosciences is a biotech R&D company designing and providing a broad range of novel and high quality functionalized polyoxazoline polymer. Polyoxazoline (POX) is a unique water-soluble, biocompatible, non-immunogenic and safe polymer, and has been extensively studied in both therapeutic and diagnostic areas. Panora Biosciences has expertise in modification of drug-like compounds with a polymer at molecular level. Conjugation of a biopharmaceutical polymer to a drug molecule provides a way to discover a new chemical entity (NCE) with improved pharmaceutical properties such as drug metabolism and pharmacokinetics (DMPK) and receptor binding profiles.
Panora Biosciences, Inc revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Panora Biosciences, Inc has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Panora Biosciences, Inc has never raised funding before.
Frequently asked questions
4.8
40,000 users



